Targeting the RAS-dependent chemoresistance: The Warburg connection
- 1 February 2019
- journal article
- review article
- Published by Elsevier in Seminars in Cancer Biology
- Vol. 54, 80-90
Abstract
No abstract availableKeywords
This publication has 80 references indexed in Scilit:
- Discovery of Small Molecules that Bind to K‐Ras and Inhibit Sos‐Mediated ActivationAngewandte Chemie International Edition, 2012
- Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose MetabolismCell, 2012
- Small-molecule ligands bind to a distinct pocket in Ras and inhibit SOS-mediated nucleotide exchange activityProceedings of the National Academy of Sciences, 2012
- Glutamine addiction: a new therapeutic target in cancerTrends in Biochemical Sciences, 2010
- Q's next: the diverse functions of glutamine in metabolism, cell biology and cancerOncogene, 2009
- Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal CancerNew England Journal of Medicine, 2009
- K-rasMutations and Benefit from Cetuximab in Advanced Colorectal CancerNew England Journal of Medicine, 2008
- Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in miceProceedings of the National Academy of Sciences, 2008
- Predicting the future burden of cancerNature Reviews Cancer, 2005
- Phosphatidylinositol-3-OH kinase direct target of RasNature, 1994